745 related articles for article (PubMed ID: 29463395)
1. [Cardiovascular protection of diabetic patient with chronic renal disease and particular case of end-stage renal disease in elderly patients].
Zaoui P; Hannedouche T; Combe C
Nephrol Ther; 2017 Jun; 13(6S):6S16-6S24. PubMed ID: 29463395
[TBL] [Abstract][Full Text] [Related]
2. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
Dussol B; Berland Y
Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
[TBL] [Abstract][Full Text] [Related]
3. [Risk and prevention of diabetic nephropathy].
Ravera M; Re M; Deferrari G
G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
[TBL] [Abstract][Full Text] [Related]
4. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
[TBL] [Abstract][Full Text] [Related]
5. Slowing the progression of diabetic nephropathy and its cardiovascular consequences.
McCullough PA; Bakris GL; Owen WF; Klassen PS; Califf RM
Am Heart J; 2004 Aug; 148(2):243-51. PubMed ID: 15308993
[TBL] [Abstract][Full Text] [Related]
6. Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021.
Banerjee D; Winocour P; Chowdhury TA; De P; Wahba M; Montero R; Fogarty D; Frankel AH; Karalliedde J; Mark PB; Patel DC; Pokrajac A; Sharif A; Zac-Varghese S; Bain S; Dasgupta I;
BMC Nephrol; 2022 Jan; 23(1):9. PubMed ID: 34979961
[TBL] [Abstract][Full Text] [Related]
7. [Control of arterial pressure in diabetic nephropathy].
Luño J; García de Vinuesa S
Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
[No Abstract] [Full Text] [Related]
8. Concomitant macro and microvascular complications in diabetic nephropathy.
Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
[TBL] [Abstract][Full Text] [Related]
9. [Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy].
Parving HH; Brenner BM; Cooper ME; de Zeeuw D; Keane WF; Mitch WE; Remuzzi G; Snapinn SM; Zhang Z; Shahinfar S
Ugeskr Laeger; 2001 Oct; 163(40):5514-9. PubMed ID: 11601117
[TBL] [Abstract][Full Text] [Related]
10. The role of renin-angiotensin-aldosterone system-based therapy in diabetes prevention and cardiovascular and renal protection.
Abuissa H; O'Keefe J
Diabetes Obes Metab; 2008 Dec; 10(12):1157-66. PubMed ID: 18494810
[TBL] [Abstract][Full Text] [Related]
11. The renin-angiotensin system and its blockade in diabetic renal and cardiovascular disease.
Kalantarinia K; Okusa MD
Curr Diab Rep; 2006 Feb; 6(1):8-16. PubMed ID: 16522275
[TBL] [Abstract][Full Text] [Related]
12. Impact of the renin-angiotensin-aldosterone-system on cardiovascular and renal complications in diabetes mellitus.
Hayashi T; Takai S; Yamashita C
Curr Vasc Pharmacol; 2010 Mar; 8(2):189-97. PubMed ID: 19485896
[TBL] [Abstract][Full Text] [Related]
13. Microvascular complications of diabetes mellitus: renal protection accompanies cardiovascular protection.
Brown WV
Am J Cardiol; 2008 Dec; 102(12A):10L-13L. PubMed ID: 19084084
[TBL] [Abstract][Full Text] [Related]
14. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive treatment and multifactorial approach for renal protection in diabetes.
Fioretto P; Solini A
J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S18-21. PubMed ID: 15938027
[TBL] [Abstract][Full Text] [Related]
16. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
Coccheri S
Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
[TBL] [Abstract][Full Text] [Related]
17. Preventing end-stage renal disease.
Mogensen CE
Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
[TBL] [Abstract][Full Text] [Related]
18. Another patient with a natural history of diabetic nephropathy: current situation and means of prevention.
Heras M; Saiz A; Sánchez R; Fernández-Reyes MJ; Molina A; Rodríguez MA
Nefrologia; 2011; 31(1):108-10. PubMed ID: 21270923
[No Abstract] [Full Text] [Related]
19. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
20. [DIABETIC NEPHROPATHY AS A CAUSE OF CHRONIC KIDNEY DISEASE].
Kos I; Prkačin I
Acta Med Croatica; 2014 Dec; 68(4-5):375-81. PubMed ID: 26285470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
